ICUI
Closed
Icu Medical Inc
134.95
+2.80 (+2.12%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 132.15
Day's Range: 129.86 - 137.1
Send
sign up or login to leave a comment!
When Written:
161.31
ICU Medical Inc is a global medical device company that specializes in the development, manufacturing, and sale of innovative medical devices used in critical care and oncology applications. The company was founded in 1984 and is headquartered in San Clemente, California.
ICU Medical's product portfolio includes a range of infusion therapy products, such as IV sets, pumps, and connectors, as well as oncology products, including closed system transfer devices and needle-free connectors. The company's products are designed to improve patient safety, reduce the risk of infection, and enhance healthcare provider efficiency.
ICU Medical has a global presence, with operations in North America, Europe, and Asia. The company has a strong focus on research and development, with a team of engineers and scientists dedicated to developing new products and improving existing ones.
In 2017, ICU Medical acquired the Hospira Infusion Systems business from Pfizer, further expanding its presence in the infusion therapy market. The acquisition also allowed ICU Medical to become the exclusive supplier of IV solutions to the US Department of Veterans Affairs.
ICU Medical is committed to sustainability and has implemented initiatives to reduce its environmental impact, such as reducing waste and energy consumption in its manufacturing facilities.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
ICU Medical's product portfolio includes a range of infusion therapy products, such as IV sets, pumps, and connectors, as well as oncology products, including closed system transfer devices and needle-free connectors. The company's products are designed to improve patient safety, reduce the risk of infection, and enhance healthcare provider efficiency.
ICU Medical has a global presence, with operations in North America, Europe, and Asia. The company has a strong focus on research and development, with a team of engineers and scientists dedicated to developing new products and improving existing ones.
In 2017, ICU Medical acquired the Hospira Infusion Systems business from Pfizer, further expanding its presence in the infusion therapy market. The acquisition also allowed ICU Medical to become the exclusive supplier of IV solutions to the US Department of Veterans Affairs.
ICU Medical is committed to sustainability and has implemented initiatives to reduce its environmental impact, such as reducing waste and energy consumption in its manufacturing facilities.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!